• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

FDA approves improved Oracle Micro catheter

Article

Endosonics has received Food and Drug Administration approvalfor its latest version of the Oracle Micro line of ultrasoundimaging catheters. The Pleasanton, CA, firm announced last monththat the FDA had given the go-ahead to Oracle Micro Plus,

Endosonics has received Food and Drug Administration approvalfor its latest version of the Oracle Micro line of ultrasoundimaging catheters. The Pleasanton, CA, firm announced last monththat the FDA had given the go-ahead to Oracle Micro Plus, whichcombines on a single catheter a solid-state imaging transducerand a percutaneous transluminal coronary angioplasty (PTCA) balloon.Endosonics said Oracle Micro Plus confers significant advantagesover its previous version of the product, which the FDA approvedlast year (SCAN 10/26/94). Oracle Micro Plus is especially wellsuited for coronary stenting procedures, the company said.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.